Andessu net profit of $1.55 billion in the first three quarters of 2016 results or above budget

Blue Star Andesu Co., Ltd(600299.SH) released its third quarter 2016 report on Oct29The report showed that Andesu achieved operating income of RMB8.09 billion and net cash flow from operating activities of RMB2.18 billion in the first three quarters, while net income attributable to shareholders in the first three quarters was RMB1.55 billion, with basic earnings per share of RMB0.58, exceeding the 2016 budget levelmEf
Third-quarter results exceeded expectationsmEfreport showed that Andesu achieved stable and good earnings in the first three quarters of 2016, compared with 2015, the whole market environment of methionine has changed significantly, but Andesu can still maintain a competitive environment in a challenging competitive environment to maintain an operating margin of nearly 30%, leading the industrymEf
The report continued that the excellent performance was mainly due to: 1) the gradual production of new production capacity, especially the Nanjing liquid methionine plant phase II project, to support sales growth as expected, 2) rich product portfolio, vitamin product prices and profits are up year-on-year, 3) the promotion and business development of specialty products in the market Good shape has had a positive impact on performance; 4) Andesu implemented stronger cost control management measures to continue to achieve higher profit levels in a large market environment with falling prices, 5) favourable external environments, lower crude oil prices and a strong dollar brought lower raw material costs and higher dollar-denominated revenuesmEf
Aytha said in its earnings report that net profit attributable to shareholders in the first three quarters of 2016 was up 26% from the same period in 2015 and exceeded the initial annual budgetmEf
　　In addition, operating cash flow of up to $2.18 billion is a solid financial basis for future development the foundation of a solid leadership position in the functional products
mEf is able to sustain industrial investment sourcing to ensure sustained and profitable growth, building on its own strong capital In the future, the company will actively achieve sustainable development in the future as the goal, the expansion of existing capacity and debottleneck closely combined, and actively study the feasibility of establishing a new production platform mEf
　　With the world's leading process, Andesu is one of the lowest production costs, the best quality and the best reliability of liquid methionine Andesso has successfully increased its market share from 23% to 27% over the past four years and is currently a leader in the liquid methionine market mEf
　　Andesu said that large-scale investment in the field of methionine-related research continues to ensure that we always have the most cutting-edge technology, but also hope to drive breakthrough innovation throughout the industry mEf new product development to support the new blueprint mEf in order to consolidate market leadership and open up new markets, Andesu in the past few years has been developing new products, its total in France and China has 7 laboratories, annual research and development spending of up to 220 million yuan, which has become and Isu forward and development of a strong driving force In order to ensure the goal of achieving sustainable development, Andesu will develop specialty products as a second pillar of the business, and will invest sufficient financial resources in new product development mEf
　　In the first three quarters of 2016, Andesu and Novixin launched and promoted a new poultry probiotic product, Alterion, which increases the conversion rate of animal feed by 2% to 2.5% and can be used as an alternative to antibiotics mEf
　　Sales of ruminant products have increased nearly fivefold over the past six years, and EBITDA (EBITDA) has increased significantly in response to Andesu's continued focus and investment in ruminant products over the past six years Despite the continuing global dairy crisis in 2016, the company remains confident about the future market prospects for ruminant products mEf
　　Mr Andesu said he was confident in its strength and expected better-than-expected results in 2016 At the same time, have the confidence to achieve the best enterprise management, the best marketing, to cope with fierce market competition mEf Blue Star Andy Su Co., Ltd (600299.SH) released its third quarter 2016 report on Oct 29 The report showed that Andesu achieved operating income of RMB8.09 billion and net cash flow from operating activities of RMB2.18 billion in the first three quarters, while net income attributable to shareholders in the first three quarters was RMB1.55 billion, with basic earnings per share of RMB0.58, exceeding the 2016 budget level mEf
　　Third-quarter results exceeded expectations mEf report showed that Andesu achieved stable and good earnings in the first three quarters of 2016, compared with 2015, the whole market environment of methionine has changed significantly, but Andesu can still maintain a competitive environment in a challenging competitive environment to maintain an operating margin of nearly 30%, leading the industry mEf
　　The report continued that the excellent performance was mainly due to: 1) the gradual production of new production capacity, especially the Nanjing liquid methionine plant phase II project, to support sales growth as expected, 2) rich product portfolio, vitamin product prices and profits are up year-on-year, 3) the promotion and business development of specialty products in the market Good shape has had a positive impact on performance; 4) Andesu implemented stronger cost control management measures to continue to achieve higher profit levels in a large market environment with falling prices, 5) favourable external environments, lower crude oil prices and a strong dollar brought lower raw material costs and higher dollar-denominated revenues mEf
　　Aytha said in its earnings report that net profit attributable to shareholders in the first three quarters of 2016 was up 26% from the same period in 2015 and exceeded the initial annual budget mEf
　　In addition, operating cash flow of up to $2.18 billion is a solid financial basis for future development the foundation of a solid leadership position in the functional products
mEf is able to sustain industrial investment sourcing to ensure sustained and profitable growth, building on its own strong capital In the future, the company will actively achieve sustainable development in the future as the goal, the expansion of existing capacity and debottleneck closely combined, and actively study the feasibility of establishing a new production platform mEf
　　With the world's leading process, Andesu is one of the lowest production costs, the best quality and the best reliability of liquid methionine Andesso has successfully increased its market share from 23% to 27% over the past four years and is currently a leader in the liquid methionine market mEf
　　Andesu said that large-scale investment in the field of methionine-related research continues to ensure that we always have the most cutting-edge technology, but also hope to drive breakthrough innovation throughout the industry mEf new product development to support the new blueprint mEf in order to consolidate market leadership and open up new markets, Andesu in the past few years has been developing new products, its total in France and China has 7 laboratories, annual research and development spending of up to 220 million yuan, which has become and Isu forward and development of a strong driving force In order to ensure the goal of achieving sustainable development, Andesu will develop specialty products as a second pillar of the business, and will invest sufficient financial resources in new product development mEf
　　In the first three quarters of 2016, Andesu and Novixin launched and promoted a new poultry probiotic product, Alterion, which increases the conversion rate of animal feed by 2% to 2.5% and can be used as an alternative to antibiotics mEf
　　Sales of ruminant products have increased nearly fivefold over the past six years, and EBITDA (EBITDA) has increased significantly in response to Andesu's continued focus and investment in ruminant products over the past six years Despite the continuing global dairy crisis in 2016, the company remains confident about the future market prospects for ruminant products mEf
　　Mr Andesu said he was confident in its strength and expected better-than-expected results in 2016 At the same time, have the confidence to achieve the best enterprise management, the best marketing, to cope with fierce market competition mEf